Our findings that IRF1 expression contributes to the regulation of RARRES3, GBP4, and CTSS, but not to the regulation of TNFSF10, are further validated by mRNA expression data from breast cancer patients. This evidence concerns the gene PLAAT4 and breast carcinoma.